XT
CATX icon

XTX Topco’s Perspective Therapeutics CATX Stock Holding History

XTX Topco’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-82,476
Closed -$227K – 3881
2025
Q4 		$227K Buy
82,476
+22,074
+37% +$63K 0.01% 2301
2025
Q3 		$207K Buy
+60,402
New +$220K 0.01% 1820
2025
Q1 		– Sell
-18,070
Closed -$57.6K – 2471
2024
Q4 		$57.6K Sell
18,070
-19,230
-52% -$157K ﹤0.01% 1874
2024
Q3 		$498K Buy
+37,300
New +$496K 0.04% 821

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco's CATX Position: Q1 2026 in Review

XTX Topco sold out of Perspective Therapeutics (CATX) in Q1 2026, closing a stake of 82,476 shares — an estimated $227K sold.

XTX Topco first reported a position in CATX in Q3 2024 and held it in 4 quarters. The position peaked at $498K in Q3 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • XTX Topco reported no remaining Perspective Therapeutics position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 82,476 Perspective Therapeutics shares in Q1 2026, an estimated $227K.
  • XTX Topco first reported a position in Perspective Therapeutics in Q3 2024 and held it in 4 quarters.
  • XTX Topco's Perspective Therapeutics position peaked at $498K in Q3 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.